75N93025C00033
Definitive Contract
Overview
Government Description
TO ADVANCE THE DEVELOPMENT OF THE VACCINE CANDIDATE THROUGH EARLY CLINICAL DEVELOPMENT, INCLUDING THE NECESSARY PREPARATORY ACTIVITIES AND EXECUTION OF STUDIES.
Awardee
Awarding / Funding Agency
Place of Performance
Frederick, MD 21704 United States
Pricing
Cost Plus Fixed Fee
Set Aside
None
Extent Competed
Full And Open Competition
Est. Average FTE
4
Related Opportunity
None
Appili Therapeutics Usa was awarded
Definitive Contract 75N93025C00033 (75N930-25-C-00033)
worth up to $3,605,418
by the National Institute of Allergy and Infectious Diseases
in September 2025.
The contract
has a duration of 4 years 9 months and
was awarded
full & open
with
NAICS 541715 and
PSC AN11
via direct negotiation acquisition procedures with 26 bids received.
Status
(Open)
Last Modified 9/30/25
Period of Performance
9/30/25
Start Date
6/1/30
Current End Date
6/1/30
Potential End Date
Obligations
$3.6M
Total Obligated
$3.6M
Current Award
$3.6M
Potential Award
Award Hierarchy
Definitive Contract
75N93025C00033
Subcontracts
Activity Timeline
People
Suggested agency contacts for 75N93025C00033
Competition
Number of Bidders
26
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Awardee UEI
HREVE7N46SM8
Awardee CAGE
9D4H9
Agency Detail
Awarding Office
75N930 NATIONAL INSTITUTES OF HEALTH NIAID
Funding Office
75N930
Created By
hhschargett
Last Modified By
hhsjbryan
Approved By
hhsjbryan
Legislative
Legislative Mandates
None Applicable
Performance District
MD-06
Senators
Benjamin Cardin
Chris Van Hollen
Chris Van Hollen
Representative
David Trone
Modified: 9/30/25